SHAB published 23 Feb 2024 · legal date 25 Jan 2024
Capital increase
Not assessed
Paid by converting claims
Nominal capital
100’000 → 127’406
Shares
— → 127’406
New shares, % of post-step shares
— (share counts not published)
Nouveau capital-actions: CHF 127'406, libéré à concurrence de CHF 77'406, divisé en 127'406 actions nominatives de CHF 1, avec restrictions quant à la transmissibilité selon statuts.
SHAB published 26 Nov 2025 · legal date 13 Nov 2025
Capital increase
●●○Likely financing
Paid in cash
Nominal capital
127’406 → 135’454
Shares
127’406 → 135’454
New shares, % of post-step shares
5.9% (8’048 new)
Le capital-actions de CHF 127'406 a été libéré ultérieurement à concurrence de CHF 50'000. Capital-actions: CHF 127'406, libéré à concurrence de CHF 127'406, divisé en 127'406 actions nominatives de CHF 1, avec restrictions quant à la transmissibilité selon statuts. Nouveau capital-actions entièrement libéré: CHF 135'454, divisé en 135'454 actions nominatives de CHF 1, avec restrictions quant à la transmissibilité selon statuts.
From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
The company was founded less than six years before this capital increase.+0.5
The company's purpose describes technology or life-sciences development.+0.5
Classifier score 0.65 · likely-financing threshold 0.60 · not a calibrated probability